Efficacy of Theophylline in "Irreversible" Airflow Obstruction
- 1 June 1980
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 92 (6) , 758-761
Abstract
We studied ventilatory, hemodynamic, and subjective responses to different plasma theophylline concentrations in 10 patients with "irreversible" airflow obstruction. Subjects received theophylline at doses that produced low (9.0 to 12.5 µg/mL) and high (17 to 22 µg/mL) peak plasma concentrations; subjects also received placebo. A significant (P < 0.05) dose-related difference in pulmonary function was observed between each treatment. The mean maximal increase in forced expiratory volume at 1 second over placebo was 21.3% for high-dose theophylline and 6.0% for low dose. Both treatments were well tolerated with respect to hemodynamic changes and other adverse effects. Despite improved findings in pulmonary function tests, patients were unable to distinguish either treatment from placebo in terms of improvement in breathlessness.Keywords
This publication has 15 references indexed in Scilit:
- Bronchodilator Effects of Terbutaline and Aminophylline Alone and in Combination in Asthmatic PatientsNew England Journal of Medicine, 1978
- Clinical Experience With TheophyllineJAMA, 1976
- Evaluation of oral bronchodilator therapy in asthmatic childrenThe Journal of Pediatrics, 1974
- Rational Intravenous Doses of TheophyllineNew England Journal of Medicine, 1973
- Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophyllineClinical Pharmacology & Therapeutics, 1972
- Pharmacologic effects of intravenously administered aminophylline in asthmatic childrenThe Journal of Pediatrics, 1970
- A study of the long-term effect of therapy in chronic obstructive pulmonary diseaseThe American Journal of Medicine, 1969
- Airway responsiveness in chronic obstructive pulmonary diseaseThe American Journal of Medicine, 1967
- Study of Theophylline Plasma Levels after Oral Administration of New Theophylline CompoundsBMJ, 1957
- Massachusetts Medical SocietyNew England Journal of Medicine, 1957